SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-088610
Filing Date
2023-11-20
Accepted
2023-11-20 12:41:10
Documents
78
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_60degrees.htm   iXBRL 10-Q 1361341
2 CERTIFICATION f10q0923ex31-1_60degrees.htm EX-31.1 10778
3 CERTIFICATION f10q0923ex31-2_60degrees.htm EX-31.2 10710
4 CERTIFICATION f10q0923ex32-1_60degrees.htm EX-32.1 4193
5 CERTIFICATION f10q0923ex32-2_60degrees.htm EX-32.2 4205
  Complete submission text file 0001213900-23-088610.txt   7523295

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sxtp-20230930.xsd EX-101.SCH 73353
7 XBRL CALCULATION FILE sxtp-20230930_cal.xml EX-101.CAL 55374
8 XBRL DEFINITION FILE sxtp-20230930_def.xml EX-101.DEF 369331
9 XBRL LABEL FILE sxtp-20230930_lab.xml EX-101.LAB 712385
10 XBRL PRESENTATION FILE sxtp-20230930_pre.xml EX-101.PRE 386675
72 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_60degrees_htm.xml XML 868821
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41719 | Film No.: 231421888
SIC: 2834 Pharmaceutical Preparations